A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells

Approximately 70% of breast cancer cells express oestrogen receptor alpha (ERα). Previous studies have shown that the Brefeldin A-inhibited guanine nucleotide-exchange protein 3-prohibitin 2 (BIG3-PHB2) complex has a crucial role in these cells. However, it remains unclear how BIG3 regulates the suppressive activity of PHB2. Here we demonstrate that BIG3 functions as an A-kinase anchoring protein that binds protein kinase A (PKA) and the α isoform of the catalytic subunit of protein phosphatase 1 (PP1Cα), thereby dephosphorylating and inactivating PHB2. E2-induced PKA-mediated phosphorylation of BIG3-S305 and -S1208 serves to enhance PP1Cα activity, resulting in E2/ERα signalling activation via PHB2 inactivation due to PHB2-S39 dephosphorylation. Furthermore, an analysis of independent cohorts of ERα-positive breast cancers patients reveal that both BIG3 overexpression and PHB2-S39 dephosphorylation are strongly associated with poor prognosis. This is the first demonstration of the mechanism of E2/ERα signalling activation via the BIG3-PKA-PP1Cα tri-complex in breast cancer cells.

[1]  Z. Nagy,et al.  The PHB1/2 Phosphocomplex Is Required for Mitochondrial Homeostasis and Survival of Human T Cells* , 2008, Journal of Biological Chemistry.

[2]  T. Katagiri,et al.  Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions , 2014, Scientific Reports.

[3]  A. Depaoli-Roach,et al.  Fluorescence studies on the interaction of inhibitor 2 and okadaic acid with the catalytic subunit of type 1 phosphoprotein phosphatases. , 1991, Biochemistry.

[4]  W. Miller.  Regulatory Subunits of PKA and Breast Cancer , 2002, Annals of the New York Academy of Sciences.

[5]  K. Mizuguchi,et al.  Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) is predicted to interact with its partner through an ARM-type α-helical structure , 2014, BMC Research Notes.

[6]  J. Moss,et al.  Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Bollen,et al.  Docking motif-guided mapping of the interactome of protein phosphatase-1. , 2009, Chemistry & biology.

[8]  M. Ikebe,et al.  Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase. , 2002, Biochemical and biophysical research communications.

[9]  Timothy W. Gant,et al.  Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes α and Θ , 2001 .

[10]  Yusuke Nakamura,et al.  Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. , 2004, International journal of oncology.

[11]  Kenji Mizuguchi,et al.  Applying the Naïve Bayes classifier with kernel density estimation to the prediction of protein-protein interaction sites , 2010, Bioinform..

[12]  Christer Larsson,et al.  PKCα expression is a marker for breast cancer aggressiveness , 2010, Molecular Cancer.

[13]  István Simon,et al.  The HMMTOP transmembrane topology prediction server , 2001, Bioinform..

[14]  Tingjun Hou,et al.  Structural Bioinformatics Prediction of Peptides Binding to the Pka Riiα Subunit Using a Hierarchical Strategy , 2022 .

[15]  Didier Picard,et al.  Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF , 2009, The EMBO journal.

[16]  D. Fabbro,et al.  Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. , 1993, The Journal of biological chemistry.

[17]  John D. Scott,et al.  Kinase- and phosphatase-anchoring proteins: harnessing the dynamic duo , 2002, Nature Cell Biology.

[18]  T. Haystead,et al.  Identification of the endogenous smooth muscle myosin phosphatase-associated kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Bland,et al.  Estrogen Action Via the G Protein-Coupled Receptor , GPR 30 : Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis , 2001 .

[20]  E. Avvedimento,et al.  The biological functions of A-kinase anchor proteins. , 2001, Journal of molecular biology.

[21]  P. Parker,et al.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. , 1995, The Journal of clinical investigation.

[22]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[23]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[24]  J. Yager,et al.  Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.

[25]  M. Eto,et al.  Reconstituted Human Myosin Light Chain Phosphatase Reveals Distinct Roles of Two Inhibitory Phosphorylation Sites of the Regulatory Subunit, MYPT1 , 2014, Biochemistry.

[26]  W. Zwart,et al.  PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance , 2013, Oncogene.

[27]  W. Zwart,et al.  PKA‐induced resistance to tamoxifen is associated with an altered orientation of ERα towards co‐activator SRC‐1 , 2007, The EMBO journal.

[28]  M. Kurosumi,et al.  A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude mice. , 1996, British Journal of Cancer.

[29]  K. Mizuguchi,et al.  BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells , 2015, PloS one.

[30]  Yusuke Nakamura,et al.  Activation of an Estrogen/ Estrogen Receptor Signaling by BIG3 Through Its Inhibitory Effect on Nuclear Transport of PHB2/REA in Breast Cancer , 2009 .

[31]  Emily Kang,et al.  Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor , 2015, Cell.

[32]  S. J. Tavalin,et al.  Identification of AKAP79 as a protein phosphatase 1 catalytic binding protein. , 2011, Biochemistry.

[33]  B. Katzenellenbogen,et al.  Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Setsuo Hirohashi,et al.  Label-free Quantitative Proteomics Using Large Peptide Data Sets Generated by Nanoflow Liquid Chromatography and Mass Spectrometry* , 2006, Molecular & Cellular Proteomics.

[35]  B. Katzenellenbogen,et al.  An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Marc S. Cortese,et al.  Structural Basis for Regulation of Protein Phosphatase 1 by Inhibitor-2* , 2007, Journal of Biological Chemistry.

[37]  T. Katagiri,et al.  Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer , 2015, Cancer science.

[38]  David P. Wilson,et al.  Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. , 2002, The Biochemical journal.

[39]  C. Y. Huang,et al.  On the mechanism of activation of the ATP X Mg(II)-dependent phosphoprotein phosphatase by kinase FA. , 1984, The Journal of biological chemistry.

[40]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[41]  J. Moss,et al.  Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1γ , 2007, Proceedings of the National Academy of Sciences.

[42]  L. Murphy,et al.  The Prohibitins: emerging roles in diverse functions , 2006, Journal of cellular and molecular medicine.

[43]  C. Sutherland,et al.  Analysis of phosphorylation of the myosin-targeting subunit of myosin light chain phosphatase by Phos-tag SDS-PAGE. , 2016, American journal of physiology. Cell physiology.

[44]  A. Wróbel,et al.  Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells. , 2015, Toxicology letters.

[45]  R. Weigel,et al.  Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. , 1997, Genomics.

[46]  M. Kurosumi,et al.  A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice. , 1995, British Journal of Cancer.

[47]  K. Izumi,et al.  Inhibitory effect of soluble platelet‐derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice , 2011, Cancer science.

[48]  D. Giri,et al.  Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression , 2006, Clinical Cancer Research.

[49]  K. Mizuguchi,et al.  Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells , 2013, Nature Communications.

[50]  N. Blom,et al.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. , 1999, Journal of molecular biology.

[51]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.